Ana-positive Chronic Anterior Uveitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-08-13
Clinical Trial Update: A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis [Phase 3]
Phase 3 study evaluating baricitinib in pediatric patients aged 2 to under 18 with active juvenile idiopathic arthritis-associated uveitis o…